About
Articles by Ted
-
Market Access and Valuation: Key Considerations for Multi-Indication Products
Market Access and Valuation: Key Considerations for Multi-Indication Products
By Ted Haack
Activity
-
Thanks NYSE for featuring Abdera Therapeutics on the Trading Floor as you highlighted this year's #Fierce15 Biotech companies!
Thanks NYSE for featuring Abdera Therapeutics on the Trading Floor as you highlighted this year's #Fierce15 Biotech companies!
Liked by Ted Haack
-
Check out our photo gallery from this year's Biotech CEO Summit USA >> https://bit.ly/3yDclV5. We had an amazing time and already can't wait for next…
Check out our photo gallery from this year's Biotech CEO Summit USA >> https://bit.ly/3yDclV5. We had an amazing time and already can't wait for next…
Liked by Ted Haack
-
It’s not often you get to celebrate people from every phase of your career for their accomplishments. Congrats to: 🙌 awesome clients - Masood…
It’s not often you get to celebrate people from every phase of your career for their accomplishments. Congrats to: 🙌 awesome clients - Masood…
Liked by Ted Haack
Experience & Education
Licenses & Certifications
Volunteer Experience
-
Mentor Program Advisory Board Member
Villanova School of Business
- Present 4 years
Education
The VSB Mentor Program brings Villanova students and alumni volunteers together in one-to-one relationships to support the student’s career and professional development goals. All student mentees and alumni mentors opt in and are paired based on the student’s primary field of interest, desired work location, and mutual areas of interest.
For more information, visit: https://www.linkedin.com/school/vsb-mentor-program/
Publications
-
Regenerative Medicine Is Here: New Payment Models Key To Patient Access
In Vivo
Part 3 of a 3 part Alliance for Regenerative Medicines white paper series.
Potentially curative regenerative medicine therapies are no longer theoretical, but instead have become reality. As more and more gene, cell and tissue-based therapies reach the market, the need for payment solutions is becoming more pressing. The Alliance for Regenerative Medicine has consulted with payers and other stakeholders to consider the barriers to alternative payment models and look at possible solutions.Other authorsSee publication -
New Payment And Financing Models For Curative Regenerative Medicines
InVivo
Part 2 of a 3 part Alliance for Regenerative Medicines white paper series.
Traditional payment and financing models may not be appropriate for curative treatments, some of which may require only a single administration. New payment and pricing models must
balance patient access and affordability and also adequately value curative therapies. Multiple options may be needed, and in some cases will need to be combined.Other authorsSee publication
Courses
-
NACD Director Professionalism
-
-
NACD Directorship Essentials: Risk Oversight
-
-
NACD The Art of Directorship: Strategy and Long-Term Value Creation
-
Languages
-
German
Full professional proficiency
-
English
Native or bilingual proficiency
Organizations
-
NACD
-
- Present
More activity by Ted
-
Die Ständige Impfkommission (STIKO) empfiehlt künftig allen Personen ab 75 Jahren sowie denen, die 60 bis 74 Jahre alt sind und bestimmte…
Die Ständige Impfkommission (STIKO) empfiehlt künftig allen Personen ab 75 Jahren sowie denen, die 60 bis 74 Jahre alt sind und bestimmte…
Liked by Ted Haack
-
I had fun contributing to SVB's semi-annual Healthcare Investments & Exits report. If 1H 2024 was one of the busiest ever for biopharma funding, why…
I had fun contributing to SVB's semi-annual Healthcare Investments & Exits report. If 1H 2024 was one of the busiest ever for biopharma funding, why…
Liked by Ted Haack
-
⭐ Spotlight on Barry Greene, 8400 Build your Global Board Faculty ⭐ We are thrilled to welcome Barry Greene to the faculty of the "Build Your…
⭐ Spotlight on Barry Greene, 8400 Build your Global Board Faculty ⭐ We are thrilled to welcome Barry Greene to the faculty of the "Build Your…
Liked by Ted Haack
-
I am excited to announce that Pfizer Australia reached an important milestone in the expansion of its manufacturing facility in Melbourne…
I am excited to announce that Pfizer Australia reached an important milestone in the expansion of its manufacturing facility in Melbourne…
Liked by Ted Haack
-
Happy to be collaborating with Stephanie Cline and Acumen Pharmaceuticals on characterizing the patient and study partner experience.
Happy to be collaborating with Stephanie Cline and Acumen Pharmaceuticals on characterizing the patient and study partner experience.
Liked by Ted Haack
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Ted Haack
2 others named Ted Haack are on LinkedIn
See others named Ted Haack